References

Nanoparticles: pharmacological and toxicological significance

10.1038/sj.bjp.0707130 · 2007 · External reference

Applications of nanoparticles for diagnosis and therapy of cancer

10.1259/bjr.20150207 · 2015 · External reference

Nanotechnology for molecular imaging and targeted therapy

10.1161/01.cir.0000059651.17045.77 · 2003 · External reference

Advancements in drugs restructured with nanomedicines for multiple myeloma treatment

10.1007/s40843-024-3077-0 · 2024 · External reference

Ligand-targeted liposomes for cancer treatment

10.2174/156720105774370159 · 2005 · External reference

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity

10.1016/s0168-3659(02)00212-2 · 2002 · External reference

A PEGylated dendritic nanoparticulate carrier of fluorouracil

10.1016/s0378-5173(03)00132-7 · 2003 · External reference

Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial

10.1097/00001813-200504000-00010 · 2005 · External reference

Patisiran: first global approval

10.1007/s40265-018-0983-6 · 2018 · External reference

Review of COVID-19 mRNA vaccines: BNT162b2 and mRNA-1273

10.1177/08971900211009650 · 2022 · External reference

Safety of nanoparticles in medicine

10.2174/1389450115666140804124808 · 2015 · External reference

Hepatotoxicity of nanoparticle-based anti-cancer drugs: insights into toxicity and mitigation strategies

10.2147/ijn.s543433 · 2025 · External reference

Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer: a phase 2 clinical trial

10.1001/jamaoncol.2018.2168 · 2018 · External reference

Protein corona, understanding the nanoparticle–protein interactions and future perspectives: a critical review

10.1016/j.ijbiomac.2020.12.108 · 2021 · External reference

Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties

10.1186/s12951-024-02930-6 · 2024 · External reference

Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinants

10.1039/d5nr04462f · 2026 · External reference

Pharmacokinetics and tumor delivery of nanoparticles

10.1016/j.jddst.2023.104404 · 2023 · External reference

Tracking the cellular degradation of silver nanoparticles: development of a generic kinetic model

10.1021/acsnano.4c03032 · 2024 · External reference

Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review

10.1007/s11051-023-05690-w · 2023 · External reference

Dependence of nanoparticle toxicity on their physical and chemical properties

10.1186/s11671-018-2457-x · 2018 · External reference

Tailoring supramolecular antimicrobial peptides: from self-assembled nanoarchitectures to activities

10.1007/s40843-024-3079-x · 2024 · External reference

Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations, experiments, and nature

10.1002/wnan.1362 · 2016 · External reference

Nanoparticle-based drug delivery systems: what can they really do in vivo?

10.12688/f1000research.9690.1 · 2017 · External reference

Exploring and analyzing the systemic delivery barriers for nanoparticles

2024 · External reference

Toxicological status of nanoparticles: what we know and what we don’t know

10.1016/j.cbi.2018.07.015 · 2018 · External reference

Safe nanoparticles: are we there yet?

10.3390/ijms22010385 · 2020 · External reference

Determinants and mechanisms of inorganic nanoparticle translocation across mammalian biological barriers

10.1007/s00204-023-03528-x · 2023 · External reference

Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport

10.1039/d1cs00574j · 2023 · External reference

Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects

10.1186/s12951-023-01971-7 · 2023 · External reference

Using hyperpolarized 129Xe MRI to quantify regional gas transfer in idiopathic pulmonary fibrosis

10.1136/thoraxjnl-2017-210070 · 2018 · External reference

Progress in the application of nano- and micro-based drug delivery systems in pulmonary drug delivery

10.15212/bioi-2021-0028 · 2022 · External reference

Dry powder for pulmonary delivery: a comprehensive review

10.3390/pharmaceutics13010031 · 2020 · External reference

Passage of inhaled particles into the blood circulation in humans

10.1161/hc0402.104118 · 2002 · External reference

Do inhaled carbon nanoparticles translocate directly into the circulation in humans?

10.1164/rccm.200506-865oc · 2006 · External reference

Advances in oral drug delivery

10.3389/fphar.2021.618411 · 2021 · External reference

Design principles of oral nanomedicines to overcome the delivery barriers

10.1021/acsnano.5c14045 · 2026 · External reference

Mechanisms of nanoparticle transport across intestinal tissue: an oral delivery perspective

10.1021/acsnano.3c02403 · 2023 · External reference

Nanoparticles for oral delivery: design, evaluation and state-of-the-art

10.1016/j.jconrel.2016.06.016 · 2016 · External reference

Studies of mucus in mouse stomach, small intestine, and colon. II. Gastrointestinal mucus proteome reveals Muc2 and Muc5ac accompanied by a set of core proteins

10.1152/ajpgi.00047.2013 · 2013 · External reference

Mucins in the gastrointestinal tract in health and disease

10.2741/corfield · 2001 · External reference

Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers

10.1016/j.addr.2011.12.009 · 2012 · External reference

Mimicking microbial strategies for the design of mucus-permeating nanoparticles for oral immunization

10.1016/j.ejpb.2015.01.010 · 2015 · External reference

Barrier properties of mucus

10.1016/j.addr.2008.09.008 · 2009 · External reference

Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract

10.1016/j.jaut.2009.11.006 · 2010 · External reference

Nano-formulations for transdermal drug delivery: a review

10.1016/j.cclet.2018.10.037 · 2018 · External reference

Nanomaterial-based drug delivery systems for ocular diseases: a review

2025 · External reference

Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety

10.1093/toxsci/kfj130 · 2006 · External reference

Drug delivery and nanoparticles: applications and hazards

10.2147/ijn.s596 · 2008 · External reference

Safety and toxicity issues of therapeutically used nanoparticles from the oral route

10.1155/2021/9322282 · 2021 · External reference

Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects

10.1186/s12989-016-0124-x · 2016 · External reference

Toxicity of nanoparticles

10.2174/0929867321666140601162314 · 2014 · External reference

Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals

10.1016/j.molimm.2014.06.038 · 2014 · External reference

Anti-PEG antibodies in the clinic: current issues and beyond PEGylation

10.1016/j.jconrel.2016.06.040 · 2016 · External reference

Long-circulating and target-specific nanoparticles: theory to practice

10.1016/s0031-6997(24)01494-7 · 2001 · External reference

The influence of the non-Newtonian properties of blood on the flow in large arteries: unsteady flow in a 90 degrees curved tube

10.1016/s0021-9290(99)00014-7 · 1999 · External reference

The flow of anisotropic nanoparticles in solution and in blood

2023 · External reference

Nanoparticle transport in cellular blood flow

10.1016/j.compfluid.2018.03.022 · 2018 · External reference

The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology

10.1007/s10439-007-9423-6 · 2008 · External reference

Manipulating nanoparticle transport within blood flow through external forces: an exemplar of mechanics in nanomedicine

2018 · External reference

Influence of red blood cells on nanoparticle targeted delivery in microcirculation

10.1039/c2sm06391c · 2012 · External reference

Numerical simulation of transport of deformable drug nanoparticles in capillaries

10.1360/ssv-2021-0314 · 2023 · External reference

Nanoparticle uptake by circulating leukocytes: a major barrier to tumor delivery

10.1016/j.jconrel.2018.07.031 · 2018 · External reference

Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection

10.1021/acsnano.5b05583 · 2015 · External reference

A double-edged sword: the complex interplay between engineered nanoparticles and platelets

10.1002/btm2.10669 · 2024 · External reference

Platelets are highly efficient and efficacious carriers for tumor-targeted nano-drug delivery

10.1080/10717544.2022.2053762 · 2022 · External reference

Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment

10.1073/pnas.95.8.4607 · 1998 · External reference

Paradoxical glomerular filtration of carbon nanotubes

10.1073/pnas.0913667107 · 2010 · External reference

Targeted drug delivery for tumor therapy inside the bone marrow

10.1016/j.biomaterials.2017.11.029 · 2018 · External reference

Clearance of nanoparticles from blood: effects of hydrodynamic size and surface coatings

10.1039/d3en00812f · 2024 · External reference

Biofabrication strategies and engineered in vitro systems for vascular mechanobiology

10.1002/adhm.201901255 · 2020 · External reference

Circumferential stress measurement of blood vessels model in vitro based on fiber Bragg grating sensor

10.5768/jao202243.0508003 · 2022 · External reference

Fluid shear stress enhances the phagocytic response of astrocytes

10.3389/fbioe.2020.596577 · 2020 · External reference

Shear stress regulation of nanoparticle uptake in vascular endothelial cells

10.1093/rb/rbad047 · 2023 · External reference

Disturbed flow-facilitated margination and targeting of nanodisks protect against atherosclerosis

2023 · External reference

A life under pressure: circumferential stress in the microvascular wall

10.1111/j.1742-7843.2011.00796.x · 2012 · External reference

Cyclic strain mitigates nanoparticle internalization by vascular smooth muscle cells

10.2147/ijn.s337942 · 2022 · External reference

Analysis of nanoparticle delivery to tumours

10.1038/natrevmats.2016.14 · 2016 · External reference

Biomimetic cell encapsulations by microfluidics

10.1007/s40843-024-2903-0 · 2024 · External reference

The nanoparticle biomolecule corona: lessons learned - challenge accepted?

10.1039/c5cs00217f · 2015 · External reference

Nanomedicine

10.1056/nejmra0912273 · 2010 · External reference

Hard and soft protein corona of nanomaterials: analysis and relevance

10.3390/nano11040888 · 2021 · External reference

Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles

10.1073/pnas.0608582104 · 2007 · External reference

A decade of the protein corona

10.1021/acsnano.7b08008 · 2017 · External reference

A health concern regarding the protein corona, aggregation and disaggregation

10.1016/j.bbagen.2019.02.012 · 2019 · External reference

Prolonged blood circulation and enhanced tumor accumulation of folate-targeted dendrimer-polymer hybrid nanoparticles

10.1016/j.jconrel.2014.05.006 · 2014 · External reference

Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona

10.1039/c7nr07450f · 2018 · External reference

The human in vivo biomolecule corona onto PEGylated liposomes: a proof-of-concept clinical study

2019 · External reference

Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles

10.1016/j.nano.2008.08.001 · 2009 · External reference

Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts

10.1073/pnas.0805135105 · 2008 · External reference

Differential plasma protein binding to metal oxide nanoparticles

10.1088/0957-4484/20/45/455101 · 2009 · External reference

In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape

10.1039/c7nr08322j · 2018 · External reference

Margination and adhesion of micro- and nanoparticles in the coronary circulation: a step towards optimised drug carrier design

10.1007/s10237-017-0955-x · 2018 · External reference

Mechanism of margination in confined flows of blood and other multicomponent suspensions

10.1103/physrevlett.109.108102 · 2012 · External reference

The margination of particles in areas of constricted blood flow

10.1016/j.bpj.2018.04.010 · 2018 · External reference

Use of allometry in predicting anatomical and physiological parameters of mammals

10.1258/0023677021911731 · 2002 · External reference

Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability

10.1186/2040-2384-2-14 · 2010 · External reference

Of mice and not men: differences between mouse and human immunology

10.4049/jimmunol.172.5.2731 · 2004 · External reference

To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?

10.1016/j.jconrel.2016.11.015 · 2016 · External reference

Genomic responses in mouse models poorly mimic human inflammatory diseases

10.1073/pnas.1222878110 · 2013 · External reference

64Cu-MM-302 positron emission tomography quantifies variability of enhanced permeability and retention of nanoparticles in relation to treatment response in patients with metastatic breast cancer

10.1158/1078-0432.ccr-16-3193 · 2017 · External reference

The effects of particle size, density and shape on margination of nanoparticles in microcirculation

10.1088/0957-4484/22/11/115101 · 2011 · External reference

Margination of micro- and nano-particles in blood flow and its effect on drug delivery

10.1038/srep04871 · 2014 · External reference

Particle margination and its implications on intravenous anticancer drug delivery

10.1208/s12249-014-0099-6 · 2014 · External reference

Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles

10.2217/nnm.13.191 · 2014 · External reference

A theoretical model for the margination of particles within blood vessels

10.1007/s10439-005-8976-5 · 2005 · External reference

Particles in a shear flow near a solid wall: effect of nonsphericity on forces and velocities

10.1016/s0301-9322(96)00054-7 · 1997 · External reference

The effect of particle shape on cellular interaction and drug delivery applications of micro- and nanoparticles

10.1016/j.ijpharm.2017.09.028 · 2017 · External reference

Shaping nano−/micro-particles for enhanced vascular interaction in laminar flows

10.1088/0957-4484/20/49/495101 · 2009 · External reference

The preferential targeting of the diseased microvasculature by disk-like particles

10.1016/j.biomaterials.2012.04.027 · 2012 · External reference

Understanding biophysicochemical interactions at the nano–bio interface

10.1038/nmat2442 · 2009 · External reference

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

10.1038/s41578-022-00529-7 · 2023 · External reference

Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry

10.1021/nn203892h · 2012 · External reference

The effect of nanoparticle size, shape, and surface chemistry on biological systems

10.1146/annurev-bioeng-071811-150124 · 2012 · External reference

The interplay of size and surface functionality on the cellular uptake of sub-10 nm gold nanoparticles

10.1021/acsnano.5b03521 · 2015 · External reference

How do biomolecules cross the cell membrane?

10.1021/acs.accounts.1c00560 · 2022 · External reference

Effect of physico-chemical properties of nanoparticles on their intracellular uptake

10.3390/ijms21218019 · 2020 · External reference

Polystyrene nanoparticles: sources, occurrence in the environment, distribution in tissues, accumulation and toxicity to various organisms

10.1016/j.envpol.2020.114297 · 2020 · External reference

Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques

10.1021/es0522635 · 2006 · External reference

Transcellular vesicular transport in epithelial and endothelial cells: challenges and opportunities

10.1111/tra.12533 · 2018 · External reference

Interactions of engineered nanoparticles with organs protected by internal biological barriers

10.1002/smll.201201463 · 2013 · External reference

How nanoparticles open the paracellular route of biological barriers: mechanisms, applications, and prospects

10.1021/acsnano.2c05317 · 2022 · External reference

Two-step mechanism of cellular uptake of cationic gold nanoparticles modified by (16-mercaptohexadecyl)trimethylammonium bromide

10.1021/acs.bioconjchem.6b00491 · 2016 · External reference

Oxidative stress-induced disruption of epithelial and endothelial tight junctions

2008 · External reference

Nasal epithelial barrier integrity and tight junctions disruption in allergic rhinitis: overview and pathogenic insights

10.3389/fimmu.2021.663626 · 2021 · External reference

IL-1β and the intestinal epithelial tight junction barrier

10.3389/fimmu.2021.767456 · 2021 · External reference

Biochemical and biological attributes of matrix metalloproteinases

10.1016/bs.pmbts.2017.02.005 · 2017 · External reference

Silica nanomaterials induce organ injuries by Ca2+-ROS-initiated disruption of the endothelial barrier and triggering intravascular coagulation

10.1186/s12989-020-00340-8 · 2020 · External reference

Nanoparticle size-specific actin rearrangement and barrier dysfunction of endothelial cells

10.1080/17435390.2017.1371349 · 2017 · External reference

Size and dose dependent effects of silver nanoparticle exposure on intestinal permeability in an in vitro model of the human gut epithelium

10.1186/s12951-016-0214-9 · 2016 · External reference

Paracellular delivery of protein drugs with smart EnteroPatho nanoparticles

10.1021/acsnano.4c02116 · 2024 · External reference

Cellular uptake of nanoparticles: journey inside the cell

10.1039/c6cs00636a · 2017 · External reference

Phagocytosis of microbes: insights and prospects

10.1016/s0962-8924(00)88967-9 · 1995 · External reference

Professional and non-professional phagocytes: an introduction

10.1016/s0962-8924(00)88955-2 · 1995 · External reference

Mechanisms of phagocytosis in macrophages

10.1146/annurev.immunol.17.1.593 · 1999 · External reference

Nanocarriers’ entry into the cell: relevance to drug delivery

10.1007/s00018-009-0053-z · 2009 · External reference

Insight into nanoparticle cellular uptake and intracellular targeting

10.1016/j.jconrel.2014.06.038 · 2014 · External reference

Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrophages: a possibility for antiviral drug targeting

10.1023/a:1015852732512 · 1992 · External reference

Shape induced inhibition of phagocytosis of polymer particles

10.1007/s11095-008-9626-z · 2009 · External reference

Nanoparticle uptake: the phagocyte problem

10.1016/j.nantod.2015.06.006 · 2015 · External reference

Shaping cups into phagosomes and macropinosomes

10.1038/nrm2447 · 2008 · External reference

Mechanisms of endocytosis

10.1146/annurev.biochem.78.081307.110540 · 2009 · External reference

The intracellular fate and transport mechanism of shape, size and rigidity varied nanocarriers for understanding their oral delivery efficiency

10.1016/j.biomaterials.2023.121995 · 2023 · External reference

Revealing macropinocytosis using nanoparticles

10.1016/j.mam.2021.100993 · 2022 · External reference

Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells

10.1002/mabi.200800123 · 2008 · External reference

Endocytosis: the nanoparticle and submicron nanocompounds gateway into the cell

10.3390/pharmaceutics12040371 · 2020 · External reference

Exploiting macropinocytosis for drug delivery into KRAS mutant cancer

10.7150/thno.67889 · 2022 · External reference

Clathrin: the molecular shape shifter

10.1042/bcj20200740 · 2021 · External reference

Capturing the mechanics of clathrin-mediated endocytosis

10.1016/j.sbi.2022.102427 · 2022 · External reference

Molecular mechanism and physiological functions of clathrin-mediated endocytosis

10.1038/nrm3151 · 2011 · External reference

Kinetics of cellular uptake of viruses and nanoparticles via clathrin-mediated endocytosis

10.1088/1478-3975/13/1/016005 · 2016 · External reference

Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes

10.1021/nl070363y · 2007 · External reference

Entry modes of ellipsoidal nanoparticle by membrane during clathrin-mediated endocytosis

10.1039/c9sm00751b · 2019 · External reference

Targeting of nanoparticles to the clathrin-mediated endocytic pathway

10.1016/j.bbrc.2006.11.135 · 2007 · External reference

Endocytosis by random initiation and stabilization of clathrin-coated pits

10.1016/j.cell.2004.08.017 · 2004 · External reference

The multiple faces of caveolae

10.1038/nrm2122 · 2007 · External reference

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

10.1126/science.1062688 · 2001 · External reference

De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin

10.1073/pnas.92.19.8655 · 1995 · External reference

Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities *

10.1074/jbc.m100828200 · 2001 · External reference

Deciphering the relationship between caveolae-mediated intracellular transport and signalling events

10.1016/j.cellsig.2022.110399 · 2022 · External reference

Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms

10.1034/j.1600-0854.2003.00128.x · 2003 · External reference

Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy

10.1158/0008-5472.can-17-0604 · 2017 · External reference

Differential uptake of nanoparticles by endothelial cells through polyelectrolytes with affinity for caveolae

10.1073/pnas.1322356111 · 2014 · External reference

Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae

10.1002/iub.485 · 2011 · External reference

Caveolae: mining little caves for new cancer targets

10.1038/nrc1146 · 2003 · External reference

Dual crosslinking of folic acid-modified pectin nanoparticles for enhanced oral insulin delivery

10.1016/j.bioadv.2022.212746 · 2022 · External reference

Functions of actin in endocytosis

10.1007/s00018-009-0001-y · 2009 · External reference

Nanoparticle microinjection and raman spectroscopy as tools for nanotoxicology studies

10.1039/c1an15313g · 2011 · External reference

Electrophysiological characterization of membrane disruption by nanoparticles

10.1021/nn103320j · 2011 · External reference

Freezing or wrapping: the role of particle size in the mechanism of nanoparticle-biomembrane interaction

10.1021/la301771b · 2012 · External reference

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

10.1042/bj20031253 · 2004 · External reference

Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells

10.1021/nl052396o · 2006 · External reference

Effect of the surface modification, size, and shape on cellular uptake of nanoparticles

10.1002/cbin.10459 · 2015 · External reference

The influence of the size and aspect ratio of anisotropic, porous CaCO3 particles on their uptake by cells

10.1186/s12951-015-0111-7 · 2015 · External reference

Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine

10.1016/j.addr.2019.04.008 · 2019 · External reference

MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice

10.1074/jbc.m605229200 · 2006 · External reference

Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity

10.1186/1743-8977-9-20 · 2012 · External reference

Adaptors for clathrin-mediated traffic

10.1146/annurev.cellbio.15.1.705 · 1999 · External reference

Breaking the final barrier: evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome

10.1016/j.addr.2024.115446 · 2024 · External reference

Static and dynamic light scattering by red blood cells: a numerical study

10.1371/journal.pone.0176799 · 2017 · External reference

Dynamic light scattering measurement of nanometer particles in liquids

10.1023/a:1010067107182 · 2000 · External reference

Dynamic light-scattering study of suspensions of fd virus. Application of a theory of light-scattering spectrum of weakly bending filaments

10.1021/ma00154a016 · 1985 · External reference

Noninvasive observation of skeletal muscle contraction using near-infrared time-resolved reflectance and diffusing-wave spectroscopy

10.1117/1.3503398 · 2010 · External reference

Light scattering: a review of particle characterization applications

10.1016/j.partic.2014.05.002 · 2015 · External reference

Light scattering and surface plasmons on small spherical particles

10.1038/lsa.2014.60 · 2014 · External reference

Dynamic light scattering: a practical guide and applications in biomedical sciences

10.1007/s12551-016-0218-6 · 2016 · External reference

Light scattering

1998 · External reference

Investigation of nanoparticle dispersibility and stability based on TiO2 analysis by SMLS, DLS, and SEM

10.1007/s11051-024-05959-8 · 2024 · External reference

TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis

10.1016/s0039-9140(99)00129-0 · 1999 · External reference

Effect of dilution on particle size analysis of w/o emulsions by dynamic light scattering

10.1080/01932691.2020.1712216 · 2021 · External reference

Size distribution of migrating particles and droplets under gravity in concentrated dispersions measured with static multiple light scattering

10.1016/j.jcis.2023.09.163 · 2024 · External reference

Asymmetric flow field-flow fractionation with multiangle light Scattering detection for characterization of cellulose nanocrystals

10.1021/bm300595a · 2012 · External reference

Silver and gold nanoparticles characterization by SP-ICP-MS and AF4-FFF-MALS-UV-ICP-MS in human samples used for biomonitoring

10.1016/j.talanta.2020.121404 · 2020 · External reference

Characterizing a spheroidal nanocage drug delivery vesicle using multi-detector hydrodynamic chromatography

10.1007/s00216-010-4073-1 · 2011 · External reference

Application of light scattering techniques to nanoparticle characterization and development

10.3389/fchem.2018.00237 · 2018 · External reference

Concomitant Raman spectroscopy and dynamic light scattering for characterization of therapeutic proteins at high concentrations

10.1016/j.ab.2014.11.016 · 2015 · External reference

Microwell plate-based dynamic light scattering as a high-throughput characterization tool in biopharmaceutical development

10.3390/pharmaceutics13020172 · 2021 · External reference

Dynamic light scattering and its application to control nanoparticle aggregation in colloidal systems: a review

2024 · External reference

Multivariate statistical control of emulsion and nanoparticle slurry processes based on process tomography, dynamic light Scattering, and acoustic sensor data

10.1016/s1570-7946(09)70610-8 · 2009 · External reference

High-dynamic-range blood flow rate measurement in a large-diameter vessel

10.1364/ao.432846 · 2021 · External reference

Light scattering

2002 · External reference

On the characterization of environmental nanoparticles

10.1081/ese-200027029 · 2004 · External reference

Microscopy of nanoparticulate dispersions

10.1111/jmi.12290 · 2015 · External reference

Introduction

2008 · External reference

Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties

10.1039/c8nr02278j · 2018 · External reference

pH-induced aggregation of gold nanoparticles for photothermal cancer therapy

10.1021/ja902062j · 2009 · External reference

Sensing colorimetric approaches based on gold and silver nanoparticles aggregation: chemical creativity behind the assay. A review

10.1016/j.aca.2012.08.043 · 2012 · External reference

Structural diversity in binary nanoparticle superlattices

10.1038/nature04414 · 2006 · External reference

Gold nanoparticle size and shape effects on cellular uptake and intracellular distribution of siRNA nanoconstructs

10.1021/acs.bioconjchem.7b00252 · 2017 · External reference

Advanced characterization techniques for nanoparticles for cancer research: applications of SEM and NanoSIMS for locating Au nanoparticles in cells

10.1557/opl.2013.613 · 2013 · External reference

High-resolution imaging with SEM/T-SEM, EDX and SAM as a combined methodical approach for morphological and elemental analyses of single engineered nanoparticles

10.1039/c4ra05092d · 2015 · External reference

Direct comparison of AFM and SEM measurements on the same set of nanoparticles

10.1088/0957-0233/26/8/085601 · 2015 · External reference

Inspection of morphology and elemental imaging of single nanoparticles by high-resolution SEM/EDX in transmission mode

10.1002/sia.5426 · 2014 · External reference

Dynamic light scattering distributions by any means

10.1007/s11051-021-05220-6 · 2021 · External reference

Characterization of magnetic nanoparticle by dynamic light scattering

10.1186/1556-276x-8-381 · 2013 · External reference

Determination of the translational and rotational diffusion coefficients of rodlike particles using depolarized dynamic light Scattering

10.1021/la9910273 · 2000 · External reference

Scattered light imaging enables real-time monitoring of label-free nanoparticles and fluorescent biomolecules in live cells

10.1021/jacs.9b05894 · 2019 · External reference

Laser speckle particle sizer (SPARSE) informs the size distribution of tissue granularities

10.1101/2024.09.26.615148 · 2024 · External reference

Characterizing nanoplastic suspensions of increasing complexity: inter-laboratory comparison of size measurements using dynamic light scattering

10.1039/d5en00645g · 2025 · External reference

Particle size distribution of bimodal silica nanoparticles: a comparison of different measurement techniques

10.3390/ma13143101 · 2020 · External reference

Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates

10.1007/s11095-010-0073-2 · 2010 · External reference

Physicochemical characterization of nanoparticles and their behavior in the biological environment

10.1039/c4cp00058g · 2014 · External reference

Dynamic light scattering and transmission electron microscopy in drug delivery: a roadmap for correct characterization of nanoparticles and interpretation of results

10.1039/d3mh00717k · 2023 · External reference

Polarized imaging dynamic light scattering for simultaneous measurement of nanoparticle size and morphology

10.1016/j.partic.2023.06.004 · 2024 · External reference

Asymmetrical flow field-flow fractionation on virus and virus-like particle applications

10.3390/microorganisms7110555 · 2019 · External reference

Size-exclusion chromatography of metal nanoparticles and quantum dots

10.1016/j.trac.2015.06.013 · 2016 · External reference

Assessment of protein binding using asymmetric-flow field-flow fractionation combined with multi-angle light scattering and dynamic light scattering

2024 · External reference

Quantitative characterization of gold nanoparticles by field-flow fractionation coupled online with light scattering detection and inductively coupled plasma mass spectrometry

10.1021/ac102545e · 2011 · External reference

Fast and purification-free characterization of bio-nanoparticles in biological media by electrical asymmetrical flow field-flow fractionation hyphenated with multi-angle light scattering and nanoparticle tracking analysis detection

10.3390/molecules25204703 · 2020 · External reference

Modulated 3D cross-correlation light scattering: improving turbid sample characterization

10.1063/1.3518961 · 2010 · External reference

Characterizing nanoparticles in complex biological media and physiological fluids with depolarized dynamic light scattering

10.1039/c4nr06538g · 2015 · External reference

Dual-angle interferometric scattering microscopy for optical multiparametric particle characterization

10.1021/acs.nanolett.3c03539 · 2024 · External reference

Liposomal paclitaxel in combination with cisplatin as a first line of chemotherapy in treatment of advanced NSCLC with regional lymph node metastasis: a randomized controlled trial

2013 · External reference

Lipid rafts-mediated endocytosis and physiology-based cell membrane traffic models of doxorubicin liposomes

10.1016/j.bbamem.2016.04.014 · 2016 · External reference

Biodegradation and biocompatibility of PLA and PLGA microspheres

10.1016/j.addr.2012.09.004 · 2012 · External reference

The onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

10.1038/s41565-019-0591-y · 2019 · External reference

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

10.1038/s41586-020-2622-0 · 2020 · External reference

Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer

10.1200/jco.2005.04.937 · 2005 · External reference

Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study

10.1016/j.ebiom.2023.104922 · 2024 · External reference

Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension

10.1016/j.eclinm.2023.102036 · 2023 · External reference

Structure activity relationship of dendrimer microbicides with dual action antiviral activity

10.1371/journal.pone.0012309 · 2010 · External reference

Principles of nanoparticle design for overcoming biological barriers to drug delivery

10.1038/nbt.3330 · 2015 · External reference

Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles

10.1098/rsfs.2015.0086 · 2016 · External reference

The interaction between particles and vascular endothelium in blood flow

10.1016/j.addr.2024.115216 · 2024 · External reference

Hemotoxicity of carbon nanotubes

10.1016/j.addr.2013.10.008 · 2013 · External reference

Dendrimer-based drug delivery systems: history, challenges, and latest developments

10.1186/s13036-022-00298-5 · 2022 · External reference

A short review on the applicability and use of cubosomes as nanocarriers

10.1007/s12551-023-01089-y · 2023 · External reference

Cuboidal tethered cyclodextrin frameworks tailored for hemostasis and injured vessel targeting

10.7150/thno.31159 · 2019 · External reference

Nanocrystals: a perspective on translational research and clinical studies

10.1002/btm2.10122 · 2019 · External reference

In vivo behavior of biomimetic nanoparticles: strategies for clearance avoidance, targeting, and functional delivery

10.3390/molecules30224487 · 2025 · External reference